Publications

2022

1.Wu, H., He, P., Ren, Y., Xiao, S., Wang, W., Liu, Z., Li, H., Wang, Z., Zhang, D., Cai, J., Zhou, X., Jiang, D., Fei, X., Zhao, L., Zhang, H., Liu, Z., Chen, R., Li, W., Wang, C., Zhang, S., Qin, J., Björn, N & Sun, C,.Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation. Nat Commun 13, 269 (2022). https://doi.org/10.1038/s41467-021-27723-5.

2.Sajid M, Liu L and Sun C (2022). The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. Front. Immunol. 13:887186. doi: 10.3389/fimmu.2022.887186.

3.Hu B, Sajid M, Lv R, Liu L and Sun C (2022). A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology. Front. Immunol. 13:996721. doi: 10.3389/fimmu.2022.996721.

2021

1.Yuan X, Rasul F, Nashan B, Sun C. Innate lymphoid cells and cancer: Role in tumor progression and inhibition. Eur J Immunol. 2021 Sep;51(9):2188-2205. doi: 10.1002/eji.202049033. Epub 2021 Jul 11. PMID: 34189723; PMCID: PMC8457100.

2020

1.Yuwei Wu(#), Jinyu Wang(#), Xiaodong Zheng, Yongyan Chen, Mei Huang, Qiang Huang, Weihua Xiao, Haiming Wei, Zhigang Tian, Rui Sun(*)，Sun C(*) Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model. Immunol Lett. Volume 223, July 2020.

2. Yin S, Qin J, Zhou Q, Zhu C, Li Y, Wu D, Shen Z, Guo Y, Zhou Y, Nashan B. Sequential metastasis to the liver and pancreas 4 years after gestational trophoblastic neoplasia: a case report. J Int Med Res. 2020 Nov;48(11):300060520966807.

2019

1.Sun H(#), Liu L, Huang Q, Liu H, Huang M, Wang J, Wen H, Lin R, Qu K, Li K, Wei H, Xiao W, Sun R, Tian Z, Sun C(*). Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma. Cancer Immunol Res. 2019 Sep;7(9):1535-1546.

2.Wu T(#), Li F, Chen Y, Wei H, Tian Z, Sun C(*), Sun R(*). CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model. Front Immunol. 2019 Apr 30;10:927.

3.Sun H(#)(*), Sun C(*). The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy. Front Immunol. 2019 Oct 17;10:2354.

4.Sun H(#) (*), Sun C, Xiao W, Sun R. Tissue-resident lymphocytes: from adaptive to innate immunity. Cell Mol Immunol. 2019 Mar;16(3):205-215.

5. Zong Lu(#), Peng Hui, Sun Cheng; Li Fenglei, Zheng Meijuan, Chen Yongyan, Wei Haiming, Sun Rui, Tian Zhigang(*). Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nature Communications, 2019, 10: 221.

2018

1. Sun H(#), Huang Q, Huang M, Wen H, Lin R, Zheng M, Qu K, Li K, Wei H, Xiao W, Sun R, Tian Z(*), Sun C(*). Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma. Hepatology. 2018 Nov 8. doi: 10.1002/hep.30347.

2. Sun C(#), Lan P(#), Han Q(#), Huang M, Zhang Z, Xu G, Song J, Wang J, Wei H, Zhang J, Sun R, Zhang C, Tian Z(*). Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nature Communications. 2018 Mar 28;9(1):1241.

3.Sun H(#), Xu J, Huang Q, Huang M, Li K, Qu K, Wen H, Lin R, Zheng M, Wei H, Xiao W, Sun R, Tian Z(*), Sun C(*). Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC. Cancer Res. 2018 Sep 19.CAN-18-1049.

4. Li J, Koch M, Kramer K, Kloth K, Abu Ganim AR, Scheidat S, Rinninger F, Thaiss F, Gulati A, Herden U, Achilles E, Fischer L, Nashan B. Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation. Transpl Immunol. 2018 Jun 6. pii: S0966- 3274(17)30115-6. doi: 10.1016/j.trim.2018.06.001.